Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Tg Therapeutics (TGTX)

Tg Therapeutics (TGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
TG Therapeutics: Q3 Earnings Snapshot

TG Therapeutics: Q3 Earnings Snapshot

TGTX : 29.54 (-4.23%)
TG Therapeutics Reports Third Quarter 2024 Financial Results and Raises BRIUMVI® (ublituximab-xiiy) Full Year Revenue Guidance

TGTX : 29.54 (-4.23%)
TG Therapeutics to Host Conference Call on Third Quarter 2024 Financial Results and Business Update

TGTX : 29.54 (-4.23%)
TG Therapeutics: Q2 Earnings Snapshot

TG Therapeutics: Q2 Earnings Snapshot

TGTX : 29.54 (-4.23%)
"Rule Breaker Investing" Market Cap Game Show: Bill Mann vs. Bill Barker

Our first-ever twin bill.

AAPL : 225.00 (-1.41%)
QCOM : 160.50 (-2.12%)
AMZN : 202.61 (-4.19%)
MNKD : 6.80 (-3.13%)
SNBR : 12.34 (-9.60%)
MANH : 272.62 (-2.55%)
TGTX : 29.54 (-4.23%)
QRVO : 65.61 (-1.04%)
ZM : 81.14 (-1.80%)
WOOF : 4.01 (-4.30%)
VZ : 41.65 (+1.91%)
MCD : 292.63 (-1.99%)
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises

EQNX::TICKER_START (NASDAQ:TLSA),(NYSE:LLY),(OTCQX:RHHBY),(NASDAQ:BIIB),(NASDAQ:TGTX) EQNX::TICKER_END

TLSA : 0.8905 (-3.66%)
LLY : 746.20 (-4.93%)
RHHBY : 35.8400 (-0.83%)
BIIB : 159.99 (-2.97%)
TGTX : 29.54 (-4.23%)
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises

TLSA : 0.8905 (-3.66%)
LLY : 746.20 (-4.93%)
RHHBY : 35.8400 (-0.83%)
BIIB : 159.99 (-2.97%)
TGTX : 29.54 (-4.23%)
Why TG Therapeutics Stock Was Rocketing Higher This Week

The company raised guidance for sales of its drug for relapsing multiple sclerosis.

TGTX : 29.54 (-4.23%)
TG Therapeutics: Q1 Earnings Snapshot

TG Therapeutics: Q1 Earnings Snapshot

TGTX : 29.54 (-4.23%)
TG Therapeutics: Q4 Earnings Snapshot

TG Therapeutics: Q4 Earnings Snapshot

TGTX : 29.54 (-4.23%)

Barchart Exclusives

Skip the VIX, Buy This Dividend Stock to Profit from Volatility
Instead of trying to profit from market volatility through traditional means like the VIX, investors may want to consider buying shares of Cboe Global Markets, the company behind the VIX. Cboe Global Markets is well-positioned to benefit from rising demand for derivatives trading and offers a solid dividend yield. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar